Bank of New York Mellon Corp - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 94 filers reported holding THERAPEUTICSMD INC in Q1 2015. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$399,000
+7.0%
1,049,7080.0%0.00%
Q4 2021$373,000
-49.5%
1,049,708
+5.3%
0.00%
Q3 2021$739,000
-36.1%
996,622
+2.5%
0.00%
Q2 2021$1,157,000
-27.3%
972,164
-18.2%
0.00%
Q1 2021$1,592,000
+31.2%
1,188,018
+18.5%
0.00%
Q4 2020$1,213,000
-15.6%
1,002,709
+10.1%
0.00%
Q3 2020$1,438,000
+24.8%
910,333
-1.2%
0.00%
Q2 2020$1,152,000
-91.4%
921,220
-92.7%
0.00%
-100.0%
Q1 2020$13,442,000
-57.7%
12,681,350
-3.3%
0.00%
-50.0%
Q4 2019$31,749,000
-43.5%
13,119,083
-15.3%
0.01%
-46.7%
Q3 2019$56,212,000
+2.2%
15,485,489
-26.8%
0.02%0.0%
Q2 2019$54,990,000
-53.2%
21,149,690
-12.4%
0.02%
-54.5%
Q1 2019$117,585,000
+1.2%
24,144,626
-20.8%
0.03%
-8.3%
Q4 2018$116,202,000
-41.5%
30,499,363
+0.7%
0.04%
-29.4%
Q3 2018$198,674,000
+4.5%
30,285,919
-0.6%
0.05%
-1.9%
Q2 2018$190,054,000
+20.6%
30,457,306
-5.8%
0.05%
+18.2%
Q1 2018$157,534,000
-10.0%
32,347,917
+11.6%
0.04%
-4.3%
Q4 2017$175,001,000
+27.8%
28,973,668
+12.0%
0.05%
+21.1%
Q3 2017$136,894,000
+13.5%
25,877,864
+13.0%
0.04%
+11.8%
Q2 2017$120,642,000
-17.5%
22,892,018
+12.7%
0.03%
-17.1%
Q1 2017$146,289,000
+20.1%
20,317,898
-3.8%
0.04%
+17.1%
Q4 2016$121,825,000
+14.8%
21,113,402
+35.5%
0.04%
+9.4%
Q3 2016$106,129,000
-20.6%
15,584,234
-0.9%
0.03%
-22.0%
Q2 2016$133,711,000
+63.5%
15,730,601
+23.1%
0.04%
+64.0%
Q1 2016$81,768,000
-32.1%
12,776,204
+10.1%
0.02%
-30.6%
Q4 2015$120,389,000
+79.0%
11,609,160
+1.2%
0.04%
+71.4%
Q3 2015$67,240,000
-18.6%
11,474,466
+9.2%
0.02%
-8.7%
Q2 2015$82,559,000
+28.2%
10,503,770
-1.3%
0.02%
+35.3%
Q1 2015$64,401,000
+45.6%
10,644,878
+7.1%
0.02%
+41.7%
Q4 2014$44,228,000
-7.4%
9,938,994
-3.4%
0.01%
-7.7%
Q3 2014$47,766,000
-31.3%
10,294,057
-34.6%
0.01%
+44.4%
Q2 2014$69,574,000
+146.8%
15,741,186
+252.4%
0.01%
+12.5%
Q1 2014$28,185,000
+1391.3%
4,466,663
+1130.9%
0.01%
+700.0%
Q4 2013$1,890,000
+27.5%
362,882
-28.3%
0.00%
Q3 2013$1,482,000
+92.2%
506,210
+99.0%
0.00%
Q2 2013$771,000254,4260.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q1 2015
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 4,115,116$4,979,0001.13%
GMT CAPITAL CORP 5,986,062$7,243,0000.52%
Rubric Capital Management LP 4,520,610$5,470,0000.40%
Handelsinvest Investeringsforvaltning 1,200,000$1,446,0000.22%
RA Capital Management 7,812,500$9,453,0000.13%
Knights of Columbus Asset Advisors LLC 705,105$853,0000.09%
GSA CAPITAL PARTNERS LLP 385,106$466,0000.08%
C WorldWide Group Holding A/S 6,189,834$7,490,0000.08%
Virtu Financial LLC 568,171$687,0000.07%
Aristides Capital LLC 156,747$190,0000.06%
View complete list of THERAPEUTICSMD INC shareholders